PIP4K2C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.853820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.911020E-01
Normal-vs-Stage2
1.995810E-01
Normal-vs-Stage3
8.620800E-01
Normal-vs-Stage4
8.382500E-02
Stage1-vs-Stage2
8.920800E-01
Stage1-vs-Stage3
2.799400E-01
Stage1-vs-Stage4
7.341200E-01
Stage2-vs-Stage3
2.003800E-01
Stage2-vs-Stage4
8.374800E-01
Stage3-vs-Stage4
1.939810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.807850E-01
Normal-vs-AfricanAmerican
2.440800E-01
Normal-vs-Asian
4.609600E-01
Caucasian-vs-AfricanAmerican
5.869800E-01
Caucasian-vs-Asian
2.193800E-01
AfricanAmerican-vs-Asian
7.071800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.647430E-01
Normal-vs-Female
2.085600E-01
Male-vs-Female
2.335800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.468440E-01
Normal-vs-Age(41-60Yrs)
6.854200E-02
Normal-vs-Age(61-80Yrs)
2.836000E-01
Normal-vs-Age(81-100Yrs)
3.160000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.027800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.165200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.426400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.398400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.088780E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.369600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.217000E-01
Normal-vs-Daily Drinker
2.082600E-01
Normal-vs-Weekly Drinker
4.094800E-01
Normal-vs-Occasional Drinker
1.971560E-02
Normal-vs-Social Drinker
1.096560E-01
Non Drinker-vs-Daily Drinker
7.199600E-01
Non Drinker-vs-Weekly Drinker
4.471400E-01
Non Drinker-vs-Occasional Drinker
5.347600E-02
Non Drinker-vs-Social Drinker
5.971400E-01
Daily Drinker-vs-Weekly Drinker
5.668600E-01
Daily Drinker-vs-Occasional Drinker
2.479400E-03
Daily Drinker-vs-Social Drinker
8.354000E-01
Weekly Drinker-vs-Occasional Drinker
3.297900E-03
Weekly Drinker-vs-Social Drinker
6.741400E-01
Occasional Drinker-vs-Social Drinker
1.599050E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.997890E-02
Normal-vs-Grade 2
9.841800E-03
Normal-vs-Grade 3
3.284000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.520600E-01
Grade 1-vs-Grade 3
1.546160E-01
Grade 1-vs-Grade 4
1.997890E-02
Grade 2-vs-Grade 3
1.226200E-01
Grade 2-vs-Grade 4
9.841800E-03
Grade 3-vs-Grade 4
3.284000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.232200E-01
Normal-vs-NonDiabetic
1.451160E-01
Diabetic-vs-NonDiabetic
7.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.262590E-01
Normal-vs-NoPancreatitis
1.806040E-01
Pancreatitis-vs-NoPancreatitis
8.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.105150E-01
Normal-vs-N1
2.194600E-01
N0-vs-N1
5.857800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.660100E-02
Normal-vs-TP53-NonMutant
1.793840E-01
TP53-Mutant-vs-TP53-NonMutant
2.597600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
